THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myelodysplastic syndrome. Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at r...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Croatian English |
| Published |
02.08.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myelodysplastic syndrome. Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myelodysplastic syndrome. |
|---|---|
| AbstractList | Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myelodysplastic syndrome. Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myelodysplastic syndrome. |
| Author | Stuart, Monic J Kelsey, Stephen |
| Author_xml | – fullname: Stuart, Monic J – fullname: Kelsey, Stephen |
| BookMark | eNqNi70KwjAURjPo4N87XHAWai3u0d6QC01SkovgVIrESdJCxec3iKOD08f5OGcpZmlIcSFerBEYG2fQy4BAVtOJ2Hkgg_kPLBlUxo_nUbJBy-AUmGuuWu8aUjlluiDUFJyv0QeQtv4lWHRtI4MJazG_948pbr67EluFfNa7OA5dnMb-FlN8dtq3ZVFWxbGsmPeH_6w3DLY9iA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | INHIBITOR TELOMERAZE IMETELSTAT ZA LIJEČENJE MIJELOPROLIFERATIVNIH POREMEĆAJA I MIJELOPROLIFERATIVNE NEOPLAZME |
| ExternalDocumentID | HRP20240624TT1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_HRP20240624TT13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 16 05:56:47 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Croatian English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_HRP20240624TT13 |
| Notes | Application Number: HR2024P000624T |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240802&DB=EPODOC&CC=HR&NR=P20240624T1 |
| ParticipantIDs | epo_espacenet_HRP20240624TT1 |
| PublicationCentury | 2000 |
| PublicationDate | 20240802 |
| PublicationDateYYYYMMDD | 2024-08-02 |
| PublicationDate_xml | – month: 08 year: 2024 text: 20240802 day: 02 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | Geron Corporation |
| RelatedCompanies_xml | – name: Geron Corporation |
| Score | 3.5634656 |
| Snippet | Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240802&DB=EPODOC&locale=&CC=HR&NR=P20240624T1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpW3Gt_dgeinRtSitrU9o45tPo2gxF2MZW9d_3Ejbng-wtyR0HObjcXZL7HUL3Nje53isf1VLrctWwK1stTN5ROyXEBuAvebcS1chxYoUvxvPIHDXQx6YWRuKEfktwRLCoEuy9luf1YnuJ5cu_lauHyTsszZ8C5vjKOjsWeF0dXfH7DkmpTz3F85wwU5LMSSXR0g0GqdKeiKMF0D4Z9kVZyuKvTwmO0X4K4mb1CWq8LVvo0Nu0Xmuhg3j94g3DtfGtTtEXCwlmZEBFc86c4CgJo37EaIajmMB6zlyGIanDki8jLhNA_ZgGOH4VjTYzOogCIi6lhgT7UQ7pH8ly7Cb-fwwJoenAzeP8DN0FhHmhChsY_6prHGbbzTLt8Rw1Z_MZv0CYW6VhWZU2rQrLAN84mfKeVnbtnj0tClPnl6i9S9LVbvI1OhIz-TlOb6NmvfzkN-Cw68mtVPQPHBiStw |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8Wt68f2UKRrU1rtF20c82l0bYYibGOr-u-bhM35IHsLd8dBApfLL8n9DuDeoBpV-kVXLjo9KqtGaci5Rttyu2BnA5Yvaa_k1chhpHsv6tNIG9XgY1MLI3hCvwU5IouogsV7JfbrxfYSyxF_K1cPk3cmmj-6xHSkNTrmfF1tRXIGJk5iJ7Yl2za9VIpSMxFKXVEJg0p7BsOEnGgfDwe8LGXxN6e4R7CfMHez6hhqb8smNOxN67UmHITrF282XAff6gS-iIcRwUHMm3NmGPmR5w98EqfIDzGTZ8QiiIE6JOxSbBFO1I9iF4WvvNFmGge-i_ml1BAjx88Y_MNphqzI-c8gwnESWFmYncKdi4ntyWwC49_lGnvpdrKk0z2D-mw-o-eAqF6oul52pmWuqyw3Tqa03yl6Rt-Y5rmm0Ato7fJ0uVt9Cw2PhME48KPnKzjkGvFRTmlBvVp-0muWvKvJjVj0Hx9VlaI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THE+TELOMERASE+INHIBITOR+IMETELSTAT+FOR+THE+TREATMENT+OF+MYELOPROLIFERATIVE+DISORDERS+AND+MYELOPROLIFERATIVE+NEOPLASMS&rft.inventor=Stuart%2C+Monic+J&rft.inventor=Kelsey%2C+Stephen&rft.date=2024-08-02&rft.externalDBID=T1&rft.externalDocID=HRP20240624TT1 |